Following a full submission
AWMSG advice |
|||
| Status: Recommended | |||
Tirbanibulin (Klisyri®) is recommended as an option for use within NHS Wales for the field treatment of non hyperkeratotic, non hypertrophic actinic keratosis (Olsen grade 1) of the face or scalp in adults. |
|||
|
|||
Medicine details |
|||
| Medicine name | tirbanibulin (Klisyri®) | ||
| Formulation | 10 mg/g ointment | ||
| Reference number | 4076 | ||
| Indication | For the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (Olsen grade 1) of the face or scalp in adults |
||
| Company | Almirall Ltd | ||
| BNF chapter | Skin | ||
| Assessment type | Full | ||
| Status | Recommended | ||
| Advice number | 0122 | ||
| NMG meeting date | 05/01/2022 | ||
| AWMSG meeting date | 09/02/2022 | ||
| Date of issue | 23/02/2022 | ||